Xeltis
9 known investors
Find your way into Xeltis
Sign up to see every warm intro you have to Xeltis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Xeltis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
Founders & leadership
Investors · 9
How we know: Kurma Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: VI Partners's portfolio page · med-techinsights.com · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Ysios Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: med-techinsights.com · funding news · Not right? Tell us
How we know: med-techinsights.com · funding news · Not right? Tell us
Also in the syndicate · 3
In the news
Frequently asked questions
- What does Xeltis do?
- Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
- Who are Xeltis's investors?
- Xeltis's investors include Kurma Partners, VI Partners, Ysios Capital, Amadeus Capital Partners, EQT Life Sciences, Invest-NL.






